Soelberg-Sørensen P - Search Results

1

Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients.

Dai Y, Masterman T, Huang WX, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Oturai A, Ryder LP, Soelberg-Sørensen P, Svejgaard A, Hillert J. Dai Y, et al. Mult Scler. 2001 Jun;7(3):157-63. doi: 10.1177/135245850100700304. Mult Scler. 2001. PMID: 11475438

2

Gene expression analysis of interferon-beta treatment in multiple sclerosis.

Sellebjerg F, Datta P, Larsen J, Rieneck K, Alsing I, Oturai A, Svejgaard A, Soelberg Sørensen P, Ryder LP. Sellebjerg F, et al. Mult Scler. 2008 Jun;14(5):615-21. doi: 10.1177/1352458507085976. Epub 2008 Apr 11. Mult Scler. 2008. PMID: 18408020 Clinical Trial.

3

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.

Sellebjerg F, Royen L, Soelberg Sørensen P, Oturai AB, Jensen PEH. Sellebjerg F, et al. Mult Scler. 2019 Oct;25(11):1444-1451. doi: 10.1177/1352458518794308. Epub 2018 Aug 16. Mult Scler. 2019. PMID: 30113249

4

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.

Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A. Laursen JH, et al. Mult Scler. 2015 Oct;21(11):1414-22. doi: 10.1177/1352458514563590. Epub 2014 Dec 22. Mult Scler. 2015. PMID: 25533295

5

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.

Sellebjerg F, Krakauer M, Hesse D, Ryder LP, Alsing I, Jensen PE, Koch-Henriksen N, Svejgaard A, Soelberg Sørensen P. Sellebjerg F, et al. Eur J Neurol. 2009 Dec;16(12):1291-8. doi: 10.1111/j.1468-1331.2009.02716.x. Epub 2009 Jun 22. Eur J Neurol. 2009. PMID: 19558503

6

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.

Andersen O, Elovaara I, Färkkilä M, Hansen HJ, Mellgren SI, Myhr KM, Sandberg-Wollheim M, Soelberg Sørensen P. Andersen O, et al. J Neurol Neurosurg Psychiatry. 2004 May;75(5):706-10. doi: 10.1136/jnnp.2003.010090. J Neurol Neurosurg Psychiatry. 2004. PMID: 15090564 Free PMC article. Clinical Trial.

7

Editorial.

Hillert J, Soelberg Sørensen P. Hillert J, et al. J Neurol. 2008 Mar;255 Suppl 1:1-2. doi: 10.1007/s00415-008-1001-9. J Neurol. 2008. PMID: 18317670 No abstract available.

8

A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.

Damotte V, Guillot-Noel L, Patsopoulos NA, Madireddy L, El Behi M; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; De Jager PL, Baranzini SE, Cournu-Rebeix I, Fontaine B. Damotte V, et al. Genes Immun. 2014 Mar;15(2):126-32. doi: 10.1038/gene.2013.70. Epub 2014 Jan 16. Genes Immun. 2014. PMID: 24430173 Free article.

9

The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.

International Multiple Sclerosis Genetics Consortium. International Multiple Sclerosis Genetics Consortium. PLoS One. 2011 Apr 28;6(4):e18813. doi: 10.1371/journal.pone.0018813. PLoS One. 2011. PMID: 21552549 Free PMC article.

10

Defining active progressive multiple sclerosis.

Sellebjerg F, Börnsen L, Ammitzbøll C, Nielsen JE, Vinther-Jensen T, Hjermind LE, von Essen M, Ratzer RL, Soelberg Sørensen P, Romme Christensen J. Sellebjerg F, et al. Mult Scler. 2017 Nov;23(13):1727-1735. doi: 10.1177/1352458517726592. Epub 2017 Aug 23. Mult Scler. 2017. PMID: 28831853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page